Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes-A Real-World Study (China PDS)

被引：0
|
作者：
Chen, Lixian
Han, Ying
Hu, Daqing
Jin, Hui
Yang, Nailong
Shi, Xiaoyun
Li, Quanmin
Liang, Linlang
Zang, Li
Liu, Mingming
He, James
Mu, Yiming
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-2267-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Glycemic effects of vildagliptin and metformin combination therapy in Indian patients with type 2 diabetes: An observational study
    Chatterjee, Sanjay
    Chatterjee, Sudip
    JOURNAL OF DIABETES, 2014, 6 (03) : 237 - 242
  • [42] REAL-WORLD EFFECTIVENESS OF SGLT2 INHIBITORS VS METFORMIN AS FIRST-LINE THERAPY IN TYPE 2 DIABETES
    Rodriguez, P.
    Gratzl, S.
    Lee, R.
    Gilson, S.
    Smits, P.
    Stucky, N.
    Gluckman, T. J.
    VALUE IN HEALTH, 2023, 26 (06) : S32 - S33
  • [43] Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
    Li Zang
    Yin Han
    Lixian Chen
    Daqing Hu
    Hui Jin
    Nailong Yang
    Xiaoyun Shi
    Linlang Liang
    Mingming Liu
    Hong Fan
    Quanmin Li
    Yiming Mu
    Diabetes Therapy, 2019, 10 : 1391 - 1405
  • [44] Clinical effectiveness of combination therapy with dulaglutide, SGLT2 inhibitor and metformin with or without insulin in Indian adults with type 2 diabetes: a real-world retrospective study
    Bhattacharyya, Supratik
    CLINICAL DIABETOLOGY, 2020, 9 (04): : 233 - 238
  • [45] Comparison of Efficacy of Add-on Therapy of Teneligliptin Versus Pioglitazone among Type 2 Diabetes Mellitus Patients Ineptly Controlled on Dual Therapy of Metformin Plus Sulfonylurea
    Kumar, Vanjari Nikhil
    Konyala, Sandeep Reddy
    Bandaru, Siva Subrahmanyam
    Puchchakayala, Goverdhan
    JOURNAL OF DIABETOLOGY, 2019, 10 (02) : 76 - 82
  • [46] Duration of maintenance of dual therapy with metformin and sitagliptin in type 2 diabetes: the Odyssee observational study
    Valensi, P.
    De Pouvourville, G.
    Benard, N.
    Chanut-Vogel, C.
    Kempf, C.
    Moisan, C.
    Dallongeville, J.
    DIABETOLOGIA, 2014, 57 : S367 - S367
  • [47] Triple therapy in Type 2 diabetes: benefits of insulin glargine over rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
    Rosenstock, J
    Sugimoto, D
    Strange, P
    Stewart, J
    Rak, ES
    Dailey, G
    DIABETOLOGIA, 2004, 47 : A57 - A57
  • [48] Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study
    Sándor Szépkúti
    Szilvia Bandur
    Gábor Kovács
    Tamás Ferenci
    Márk M. Svébis
    Piroska Turbucz
    Ádám G. Tabák
    BMC Endocrine Disorders, 22
  • [49] Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study
    Szepkuti, Sandor
    Bandur, Szilvia
    Kovacs, Gabor
    Ferenci, Tamas
    Svebis, Mark M.
    Turbucz, Piroska
    Tabak, Adam G.
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [50] BENEFITS AND RISKS OF VILDAGLIPTIN/METFORMIN VERSUS SULPHONYLUREAS/METFORMIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS (T2DM) FROM PATIENT'S PERSPECTIVE: REAL-WORLD DATA
    Ionova, T.
    Nikitina, T.
    Kurbatova, K.
    Rodionova, A.
    VALUE IN HEALTH, 2015, 18 (07) : A615 - A615
12345